Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous v3.4.1 funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:55:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A general government funding notice and a minor site revision (Revision: v3.4.1) were added; these changes do not affect study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:32:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor textual updates: glossary display control added, capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new page revision tag 'v3.4.0' replacing 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:32:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added revision v3.3.4 and removed revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:00:47.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page's Locations section was updated to include a full list of study sites across the U.S. (Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Washington) and Canada (Alberta, Ontario, Quebec) with Revision: v3.3.3. The previous location blocks were removed and the HHS Vulnerability Disclosure section was deleted (transitioning from v3.3.2 to v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T09:10:28.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1; this appears to be a minor internal update with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:29:44.000Z thumbnail image

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.